Dr. Bob Ulrich is a General Partner and Managing Member of Vanguard Ventures, venture capital firm focused on seed and early stage investments. Bob is a seasoned veteran of both the venture capital community and the health care industry, earning prominence as a technologist, operating executive, CEO, entrepreneur and venture capital investor. He has been affiliated with Vanguard for eighteen of his twenty-one years in venture capital. During his career as a venture capitalist, he has been instrumental in raising over $400 million in funds for investment in life science and information technology start-ups, and has been responsible for over $200 million in life science investments that have created over $8 billion in value.

Bob has served as a Director of several private and public companies. He has also been the founding CEO of five start-up companies whose successes resulted in four acquisitions and one IPO. Prior to that he spent 11 years in management roles in three major corporations; Johnson and Johnson, General Electric and Monsanto. His current professional affiliations include; Member and past Director and Treasurer of the Houston Venture Capital Association; and Director, BioHouston.

Bob's formal education is in the areas of physics (BA) and materials science (MS and PhD). He also attended GE's "internal MBA" program at Crotonville, NY.